Page 3 - வெளியிடப்பட்டது அணிவகுப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19 by Zach Henderson, Chief Commercial Officer, Glooko Zach Henderson, Chief Commercial Officer, Glooko As with so many aspects of our daily lives, the impact of the COVID-19 pandemic on clinical trials was both widespread and monumental. Thousands of trials an estimated 80% of non-COVID-19 trials came to a halt or were interrupted by the pandemic, which challenged the ability to conduct trials safely and effectively and was complicated by the reality that trials often deal with the populations most at risk from COVID-19 exposure 1. In response, clinical researchers turned to a range of solutions to address the effects of the pandemic on trials. And while, in most cases, it’s premature to definitively determine which solutions will outlast the pandemic, probably the most widely used and enduring will be the decentralized model for conducting clinical trials, including the digital health

Zach hendersonEvansl hcpsLe bretonClinical trials transformation initiativeStudy of drug developmentVillanova universityTufts centerDrug administrationClinical research worldHealth monthly telehealth regional trackerHealth affairsHealth trendsLexisnexis health carePublic health emergencyDecentralized clinical trialsChief commercial officer